News - IBM's Critical Quarter: What Investors Need to Know

IBM's shares have shown a significant decline of about 21% in 2026 and are currently trading around $234, representing a 29% drop from their peak in June. The upcoming third-quarter results, set to be released on October 21, are eagerly awaited by investors. The company's performance, particularly in the software segment, will be under scrutiny, following a disappointing second quarter that failed to deliver on growth expectations. The most substantial setback occurred on July 14, when IBM reported second-quarter revenue that fell short of its projections, causing a dramatic 25% plunge in its stock. This was mainly driven by the lackluster performance of IBM’s software segment. Although software revenue increased by 5% year-over-year, growth was primarily acquisition-driven and flat without these contributions, according to CFO James Kavanaugh. Software, IBM's largest segment, generated $7.8 billion in sales for the second quarter, with profits rising 9% year-over-year to $2.5 billion. However, growth was notably slower compared to the previous quarters, casting doubt on IBM's strategy. The acquisition of the data-streaming company Confluent was a key driver of this growth, a trend that analysts see as unsustainable. Management attributed this slowdown to shifted customer spending priorities from software to hardware, and a failure to close several large deals as anticipated, explained during a call with analysts in July. Particularly, transaction processing related to IBM's mainframes dipped 8%, highlighting the challenges ahead. Despite this, certain growth areas were noted. Red Hat, IBM's hybrid cloud arm, reported an 11% increase, and the data software division saw a 19% rise. Encouragingly, about one-third of delayed deals were finalized in early Q3, offering a glimmer of hope. Nevertheless, IBM’s growth narrative heavily leans on its software division's performance, adding pressure to deliver results in ideal conditions. IBM forecasts software revenue to grow between 6% and 8% for the year, banking on stronger performance in the latter half of the year to reach near double-digit growth. Recurring revenue streams are pivotal, with a noteworthy uptick in subscription-based incomes, which rose from 7% to 8% across the first and second quarters, respectively. Overall, IBM anticipates third-quarter growth to align with its 4% to 5% annual target, a target seen as manageable following tepid 1% growth the previous quarter. The focal point of the imminent report will be software growth, particularly any recovery towards high single-digit percentages. A failure to achieve organic growth, relying instead on acquisitions, may suggest continued stagnation. Despite uncertainties, IBM’s dividend remains a key attraction. At a share price of approximately $234, the annual dividend payout of $6.76 yields close to 3%. This figure marks IBM's 31st consecutive annual increase in dividends, albeit minimally, reaffirming its commitment to shareholder returns. The dividend outlay is comfortably supported by IBM’s strong free cash flow, which reached $14.7 billion in the previous year, while anticipated to rise by $1 billion. However, speculation remains on whether this yield suffices to entice investors without an organic revenue uptick. For investors, much hinges on Wednesday’s report. A return to robust software growth and improved recurring revenue figures could renew interest in IBM stock, leveraging its dividend advantage. Conversely, if the quarter mirrors previous patterns of growth linked to acquisitions, prolonging stagnation, potential investors might choose to bide their time, waiting for a convincing turnaround in organic growth.